VISTAGEN THERAPEUTICS, INC. (VTGN) Free cash flow 2017–2024
VISTAGEN THERAPEUTICS, INC. (VTGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$25.8MFY2024 · since FY2017: -$7.5M → -$25.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$25.8M | +48.6% |
| FY2023 | -$50.2M | -10.5% |
| FY2022 | -$45.5M | -268.1% |
| FY2021 | -$12.3M | +21.6% |
| FY2020 | -$15.8M | -7.2% |
| FY2019 | -$14.7M | -62.3% |
| FY2018 | -$9.1M | -20.8% |
| FY2017 | -$7.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice